Zhou, X., Mould, D. R., Takubo, T., Sheldon‐Waniga, E., Huebner, D., Milton, A., & Venkatakrishnan, K. (2017). Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: Rationale for lower dosage in Asia. Br J Clin Pharmacol.

Zhou, Xiaofei, Diane R. Mould, Takatoshi Takubo, Emily Sheldon‐Waniga, Dirk Huebner, Ashley Milton, and Karthik Venkatakrishnan. "Global Population Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer Patients: Rationale for Lower Dosage in Asia." Br J Clin Pharmacol 2017.

Zhou, Xiaofei, et al. "Global Population Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer Patients: Rationale for Lower Dosage in Asia." Br J Clin Pharmacol 2017.